Cargando…
The network of DAB2IP-miR-138 in regulating drug resistance of renal cell carcinoma associated with stem-like phenotypes
Targeted therapy is a standard of care for metastatic renal cell carcinoma (RCC) but the response rate is not overwhelmed, which only prolongs a short survival of patients due to the onset of therapeutic resistance. Although the mechanisms are not fully understood, the presence of cancer initiating...
Autores principales: | Yun, Eun-Jin, Zhou, Jiancheng, Lin, Chun-Jung, Xu, Shan, Santoyo, John, Hernandez, Elizabeth, Lai, Chih-Ho, Lin, Ho, He, Dalin, Hsieh, Jer-Tsong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620150/ https://www.ncbi.nlm.nih.gov/pubmed/28978010 http://dx.doi.org/10.18632/oncotarget.17756 |
Ejemplares similares
-
DAB2IP in cancer
por: Liu, Liang, et al.
Publicado: (2015) -
DAB2IP modulates primary cilia formation associated with renal tumorigenesis
por: Lin, Chun-Jung, et al.
Publicado: (2020) -
Downregulation of DAB2IP Promotes Mesenchymal-To-Neuroepithelial Transition and Neuronal Differentiation of Human Mesenchymal Stem Cells
por: Chang, Sunny Li-Yun, et al.
Publicado: (2013) -
The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth
por: Tsai, Yuh-Shyan, et al.
Publicado: (2014) -
Validation of DAB2IP methylation and its relative significance in predicting outcome in renal cell carcinoma
por: Wang, Zong-Ren, et al.
Publicado: (2016)